Abstract: The present invention provides benzoxazine containing propargyl group as formula (I): wherein and The present invention provides a method of preparing a compound of formula (I). The present invention also provides a flame resistant resin.

Abstract: An inter-digital bulk acoustic resonator including a resonating structure, one or more input electrodes, one or more output electrodes, a substrate, and a supporting structure disposed on the substrate is provided. The resonating structure includes one or more resonating beams and a coupling beam. The resonating beams are connected at opposite two sides of the coupling beam respectively. The input electrodes and the output electrodes are arranged among the resonating beams in interlace. The input electrodes, the output electrodes, and the resonating beams are parallel to each other. Two ends of the coupling beam are connected to the supporting structure, such that the resonating structure is supported on the substrate.

Abstract: An electrostatic force generator is disclosed. The electrostatic force generator includes an RF AC voltage source, a capacitive module, a resonant capacitive-inductive bridge (CIB) module, a lock-in amplifier module, and a proportional-integral-derivative (PID) controller. The resonant capacitive-inductive bridge module converts the differential capacitance to a differential signal. The differential signal from the resonant capacitive-inductive bridge module is demodulated at the RF excitation frequency by the lock-in amplifier module. The PID controller receives the output signal from the lock-in amplifier module and generates two audio frequency AC signals to generate a compensation electrostatic force and maintain the capacitance balance inside the capacitive module.

Abstract: Provided are a packet transmission scheduling method in a wireless network and a packet transmission method using the same. The packet transmission scheduling method, includes storing location information and a path loss exponent of each node on a multiplexing path; calculating a Signal-to-Interference and Noise Ratio (SINR) between nodes on a predetermined path based on the stored location information; when the calculated SINR exceeds a threshold, forming the paths as a path table; and scheduling packet transmission based on the formed path table.

Abstract: A semiconductor device and a method for manufacturing the same, the method comprising: providing a semiconductor substrate; forming a dummy gate area on the substrate, forming spacers on sidewalls of the gate area, and forming source and drain areas in the semiconductor substrate on both sides of the dummy gate area, the dummy gate area comprising an interface layer and a dummy gate electrode; forming a dielectric cap layer on the dummy gate area and source and drain areas; planarizing the device with the dielectric cap layer on the source and drain areas as a stop layer; further removing the dummy gate electrode to expose the interface layer; and forming replacement gate area on the interface layer. The thickness of the gate groove may be controlled by the thickness of the dielectric cap layer, and the replacement gates of desired thickness and width may be further formed upon requirements. Thus, the aspect ratio of the gate groove is reduced and a sufficient low gate resistance is ensured.

Abstract: 4-Hydroxybenzomorphans containing carboxamide or thiocarboxamide at the 3-position are useful as analgesics, anti-diarrheal agents, anticonvulsants, antitussives and anti-addiction medications. A compound of formula is disclosed, as are pharmaceutically acceptable acid addition salts, such as acetic, benzenesulfonic (besylate), benzoic, camphorsulfonic, citric, ethenesulfonic, fumaric, gluconic, glutamic, hydrobromic, hydrochloric, isethionic, lactic, maleic, malic, mandelic, methanesulfonic, mucic, nitric, pamoic, pantothenic, phosphoric, succinic, sulfuric, tartaric acid or p-toluenesulfonic acid salts. These compounds are useful for the treatment of pain.

Abstract: A catalyst and/or precatalyst for olefin oligomerization comprising one or more coordination complexes having one or more central palladium metal atoms. Each palladium atom is bonded to four ligand donor atoms. Two of the donor atoms are group 16 elements and two of the donor atoms are group 15 elements. Also provided are neutral or cationic coordination complex dimers, so that the two palladium atoms are both bonded to one or two donor atoms from group 16, and each palladium atom is bonded to two donor atoms from group 15. In some instances, each of the two group 16 donor atoms are oxygen and each of the four group 15 donor atoms are nitrogen.

Abstract: Provided are activated collagen scaffold materials as well as their special fused active restoration factors useful for promoting tissue repair, such as bone damage repair or nerve injury repair. The special fused active restoration factors are fusion proteins comprising a collagen-binding domain (CBD) at N-/C-terminus of cytokines, wherein the collagen-binding domain is a polypeptide consisting of 7-27 amino acid residues with a conservative sequence shown in SEQ ID NO:1 at N-terminus.

Abstract: A technique capable of improving performances of a semiconductor memory device provided with a recording film having a super lattice structure is provided. The semiconductor memory device records information by changing an electric resistance of a recording film by use of a change in an atomic arrangement of the recording film. Moreover, the recording film is provided with a stacked layer portion in which a first crystal layer and a second crystal layer made of chalcogen compounds having respectively different compositions are stacked, an orientation layer that enhances an orientation of the stacked layer portion, and an adhesive layer that improves the flatness of the orientation layer.

Abstract: A liquid electrolyte can be desalinated and purified using a system that includes a first electrode and a configuration selected from (a) a second electrode and at least one distinct ion-selective boundary and (b) a second electrode that also serves as the ion-selective boundary. The ion-selective boundary is contained in the liquid conduit adjacent to a porous medium that defines pore channels filled with the liquid and that have a surface charge, and the charge of the ion-selective boundary and the surface charge of the pore channels share the same sign. A liquid including at least one charged species flows through the pore channels, forming a thin diffuse electrochemical double layer at an interface of the liquid and the charged surface of the pore channels.

Abstract: Included are a power-generation amount calculating section calculating an expected amount of power-generation being an amount of power generated by a power generating section in the future, for each predetermined period, a power-consumption amount calculating section calculating an expected amount of power-consumption being an amount of power consumed by a power load, for the predetermined period, an excess power period determining section determining an excess power period, an excess power amount calculating section calculating an expected excess power amount, and a charge/discharge control section controlling charge/discharge of a battery so that a remaining amount of the battery at the beginning of the excess power period becomes an amount resulting from subtracting the expected excess power amount from a pre-set charge amount.

Abstract: The invention is related a novel structure for Ga-68 radionuclide generator. It allows two washing solutions to pass through two Ge-68 absorbents to wash out different chemical forms of Ga-68 nuclide. The invention comprises the first method that will withdraw hydrochloric acid solution from the washing bottle and pass it through inorganic resin absorbing column to produce the radioisotope solution of Ga-68 gallium chloride, and the second method that will allow the radioisotope solution of Ga-68 gallium citrate to pass the organic resin absorbing column and then the silica-gel cartridge, and be washed by the hydrochloric acid solution to obtain the radioisotope solution of Ga-68 gallium chloride.

Abstract: Disclosed are dihydropyrimidine compounds and preparation methods, pharmaceutical compositions and uses thereof. Specifically, the compounds described herein in general formula (I), or their isomers, pharmaceutically acceptable salts or hydrates are provided, wherein each variable has the meaning as defined in the description. Also provided are a process for preparing the compounds of the general formula (I), the use of the compounds, an isomer thereof, a pharmaceutically acceptable salt thereof or a hydrate thereof as a medicament, in particular as a medicament for the treatment and/or prevention of Hepatitis B.

Abstract: The invention is based on the discovery that STM/Hop promotes proliferation of human glioblastoma-derived cells but not of normal astrocytes and that the proliferation requires the binding of STM/Hop to PrPc. The invention is directed to methods for treating cancer which rely on interfering with the Hop-PrPc interaction and to peptides, and antibodies raised against the peptides, which directly provide that interference. The invention is further based on the discovery that STI1230-245 peptide and its human homologue Hop23o-245 provide the desired interference with the STI1/Hop-PrPc interaction and inhibit the STI 1/Hop-induced proliferation of glioma and glioblastoma cells. The invention is thus further directed to methods of treating cancer that employ these peptides and functional derivatives thereof, and antibodies directed to the peptides and derivatives. The invention is further directed to means of treating cancer which involve reducing the effective amount of Hop or reducing the expression of Hop.

Abstract: Disclosed herein is a motion capture apparatus and method. The motion capture apparatus includes a three-dimensional (3D) appearance reconstruction unit for reconstructing a 3D appearance of an entity using a multi-view image obtained by capturing the entity at a T+1-th frame. A 3D skeleton generation unit generates a 3D skeleton of the T+1-th frame using the 3D appearance and a model of the entity having a motion of a T-th frame. A motion reconstruction unit reconstructs a motion of the T+1-th frame of the model by changing the motion of the model based on the 3D skeleton of the T+1-th frame.

Abstract: A vol-oxidizer for spent nuclear fuel is provided. The vol-oxidizer includes a reactor module in which the spent nuclear fuel is put and oxidized; a heating module to heat the reactor module to a high temperature; a utility module to control an inner state of the reactor module, being connected with the reactor module; a support module to support the heating module and the reactor module; a drive module to supply a driving force for transferring the spent nuclear fuel within the reactor module; a valve module to control discharge of the spent nuclear fuel being oxidized in the reactor module; and a collecting container module to collect the spent nuclear fuel being oxidized and discharged from the reactor module. The respective modules are assembled and disassembled with respect to one another.

Abstract: A method for processing cardiac signals includes accepting, from a sensor system, a set of one or more signals, the signals including components of a desired cardiac signal and components of a substantially periodic interfering signal. The method is applicable for extraction of desired fetal cardiac signals from signals with interference from the maternal cardiac signal. A periodicity of the interfering signal is determined, and one or more iterations of mitigating an effect of a component of the signals that exhibit periodicity at the determined periodicity of the interfering signal are performed. In some examples, the method further includes determining a periodicity of the desired cardiac signal, and performing one or more iterations of enhancing an effect of a component of the signals that exhibit periodicity at the determined periodicity of the desired cardiac signal.

Abstract: The invention provides an anti-hepatitis C composition including: an effective amount of limonoid compound, wherein the structure of the limonoid compound is shown as Structure (I): where R1 comprises H or OAc and R2 comprises H or COCH(CH3)2; and a pharmaceutically acceptable carrier or salt, and the anti-hepatitis C composition is used for inhibiting hepatitis C virus or treating hepatitis C. The invention also provides a method for treating hepatitis C and a method for preparing a drug for inhibiting hepatitis C viruses or treating hepatitis C.

Abstract: There is provided a power amplifier capable of increasing linear output power and efficiency without sacrificing an overall gain by employing a vector modulation function in a driving stage, with no separate vector modulator. The power amplifier includes a driving stage performing vector-modulation on an input RF signal to provide an I channel signal and a Q channel signal having different phases and amplifying the I channel signal and the Q channel signal to set gains; and a power stage amplifying power levels of the signals amplified by the driving stage.

Abstract: Double-layer capacitors capable of operating at extremely low temperatures (e.g., as low as ?80° C.) are disclosed. Electrolyte solutions combining a base solvent (e.g., acetonitrile) and a cosolvent are employed to lower the melting point of the base electrolyte. Example cosolvents include methyl formate, ethyl acetate, methyl acetate, propionitrile, butyronitrile, and 1,3-dioxolane. A quaternary ammonium salt including at least one of triethylmethylammonium tetrafluoroborate (TEMATFB) and spiro-(1,1?)-bipyrrolidium tetrafluoroborate (SBPBF4), is used in an optimized concentration (e.g., 0.10 M to 0.75 M), dissolved into the electrolyte solution. Conventional device form factors and structural elements (e.g., porous carbon electrodes and a polyethylene separator) may be employed.